A Double-Blind, Placebo-Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With Tx360® as Acute Treatment for Chronic Migraine

OBJECTIVE: To determine if repetitive sphenopalatine ganglion (SPG) blocks with 0.5% bupivacaine delivered through the Tx360® are superior in reducing pain associated with chronic migraine (CM) compared with saline. BACKGROUND: The SPG is a small concentrated structure of neuronal tissue that reside...

Descripción completa

Detalles Bibliográficos
Autores principales: Cady, Roger, Saper, Joel, Dexter, Kent, Manley, Heather R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320756/
https://www.ncbi.nlm.nih.gov/pubmed/25338927
http://dx.doi.org/10.1111/head.12458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320756/
https://www.ncbi.nlm.nih.gov/pubmed/25338927
http://dx.doi.org/10.1111/head.12458

Ejemplares similares